期刊文献+

抑制素A水平与中孕期筛查标志物及影响因素的相关性分析 被引量:2

The study on the relationship between inhibin-A level and second-trimester markers and influencing factors
原文传递
导出
摘要 目的评估中孕期母亲血清中抑制素A水平与其它血清标志物和影响因素的相关性。方法选择2008年3月-2010年12月在广州市妇女儿童医疗中心接受中孕期"三联"唐氏筛查的单胎妊娠孕妇共2802例。采用全自动酶联免疫化学发光分析法检测血清中抑制素A水平。结果 (1)在正常妊娠孕妇血清样本,抑制素A与中孕期血清标志物freeβ-hCG、AFP相关且有统计学意义(P<0.01),尤其与freeβ-hCG的相关性最高(r=0.502),而与uE3相关性没有统计学意义(P>0.05);在胎儿唐氏综合征孕妇血清样本,抑制素A与freeβ-hCG、AFP和uE3的相关性均没有统计学意义(P>0.05)。(2)135例阴道流血和40例糖尿病孕妇血清中抑制素A水平与无合并症的孕妇没有差异(P均>0.05)。孕期母亲体重与血清中抑制素A水平呈负相关(r=-0.101),并有统计学意义(P<0.01)。男性胎儿孕妇血清中抑制素A水平低于女性胎儿孕妇并有统计学意义(P<0.01)。结论血清中抑制素A水平与中孕期标志物freeβ-hCG的相关性最高,与母亲体重呈负相关性,且与胎儿性别相关,但不受孕期母亲阴道流血或糖尿病的影响。 Objective: To investigate the correlationship of second-trimester serum inhibin-A level and other markers and influencing factors.Methods: 2802 cases received second-trimester screening between 15 weeks and 20 weeks 6 days was included.Maternal serum inhibin-A concentration was determined by automatic enzyme linked immunosorbent chemiluminescence assay.Results:(1) In the normal pregnancy,there is significant relationship between inhibin-A and free β-hCG,AFP(P0.01),but not uE3(P0.05).In the affected pregnancy,there is no significant relationship between inhibin-A and free β-hCG,AFP and uE3(P0.05).(2)There is no difference between inhibin-A level in women with vaginal bleeding or gestational diabetes mellitus and women with no complications(P0.05).Serum inhibin-A levels was negatively correlated with maternal weight(r=-0.101,P0.01).There is significant difference of inhibin-A level between women with female and male fetus(P0.01).Conclusions: There is significant correlationship between serum inhibin-A level and free β-hCG,maternal weight and fetal gender,but not with maternal vaginal bleeding or gestational diabetes mellitus.
出处 《中国优生与遗传杂志》 2012年第1期53-55,15,共4页 Chinese Journal of Birth Health & Heredity
关键词 抑制素A 血清标志物 相关性 Inhibin-A Serum markers Correlation
  • 相关文献

参考文献20

  • 1Wald N J, Rodeck C, I-Iackshaw AK, et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS) [ J ]. Health Technol Assess, 2003,7: 1 -77.
  • 2Wald NJ, Rodeck C, Hackshaw AK, et al. SURUSS in perspective [ J ]. Br J Obstet Gynaecol, 2004, 111 : 521 - 531.
  • 3PA Benn, Min Fang, Egan JFX, et al. Incorporation of Inhibin - A in Second - Trimester Screening for Down Syndrome [ J 1. Obstet Gynecol,2003,101 : 451 - 454.
  • 4SW Steven Shaw, Shin - Yu Lin, Chia - Hui Lin, et al. Second trimester maternal serum quadruple test for Down syndrome screening: A Taiwan Residents population - based study [ J ]. TaiWan J Obstet Gynecol ,2010,49: 30 - 34.
  • 5Ying, SY. Inhibins, activins and follistatins : gonadal proteins modulating the secretion of folliclestimulating hormone [ J ]. Endocr Rev, 1988,9: 267 -293.
  • 6McLachlan RI, Healy DL, Lutjen PJ, et al. The maternal ovary is not the source of circulating inhibin levels during human pregnancy [ J]. Clin Endocrinol, 1987,27: 663 - 6 68.
  • 7Wald NJ, et al. Prenatal screening for Down's syndrome using inhibin -A as a serum marker[ J]. Prenat Diagn,1996,16: 143.
  • 8Cuckle HS, Holding S, Jones R, et al. Combing inhibin A with existing second - trimester markers in maternal serum screening for Down's syndrome[ J]. Prenat Diagn, 1996,16:1095 - 1100.
  • 9Spencer K. Second trimester dimeric inhibinA in Down's syndrome screening[ J ]. Prenat Diagn, 1996,16:1101 - 1110.
  • 10Wald NJ, Densem JW. Inhibin- A in Down's syndrome pregnancies: revised estimate of standard deviation [ J ]. Prenat Diagn, 1997,17 : 285 - 290.

同被引文献14

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部